Serosurvey in SARS‐CoV‐2 inactivated vaccine‐elicited neutralizing antibodies against authentic SARS‐CoV‐2 and its viral variants-Reference-Cited by-同舟云学术

Serosurvey in SARS‐CoV‐2 inactivated vaccine‐elicited neutralizing antibodies against authentic SARS‐CoV‐2 and its viral variants

Published:2022-08-15 Issue:12 Volume:94 Page:6065-6072
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Zou Lirong¹,Zhang Huan¹,Zheng Zhonghua¹,Jiang Yushan²,Huang Yushi¹,Lin Shujian¹,Yu Jianxiang¹,Deng Xiaoling¹,He Jianfeng¹,Shen Chenguang²^ORCID,Li Baisheng¹

Affiliation:

1. Institute of Microbiology Guangdong Provincial Center for Disease Control and Prevention Guangdong China

2. BSL‐3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health Southern Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28049

Reference12 articles.

1. WHO.Coronavirus (COVID‐19) Dashboard [EB/OL]. 2022. Accessed July 5 2022. https://covid19.who.int/

2. SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines

3. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies